Going forward, both CompoSecure and Husky will retain their existing trade names and be two distinct reporting segments ...

Vancouver venture capital firm was at the heart of scheme that netted millions at expense of other investors ...

Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...

Early eczema trial success and heavy trading are rapidly reshaping how investors view this drug developer, today, Jan. 20, 2026.

We came across a bullish thesis on Air Products and Chemicals, Inc. on Compounding Dividends’s Substack. In this article, we ...

DeFi Development Corp. is pivoting to a Solana-centric treasury operator, emphasizing Solana per share as anchor metric. Read ...